RETRACTED: Effect of Previous Cancer History on Survival of Patients with Different Subtypes of Breast Cancer (Retracted Article)

被引:2
|
作者
Lin, Weixun [1 ]
Chen, Yaokun [1 ]
Ji, Zeqi [1 ]
Chen, Lingzhi [1 ]
Wu, Jinyao [1 ]
Chen, Yexi [1 ]
Li, Zhiyang [1 ]
机构
[1] Shantou Univ Med Coll, Hosp 2, Dept Thyroid Breast & Hernia Surg, Shantou 515041, Guangdong, Peoples R China
关键词
ELIGIBILITY CRITERIA; TRIAL ELIGIBILITY; AGE; STRATEGIES; ADJUVANT; THERAPY; STAGE; WOMEN; RACE;
D O I
10.1155/2022/6116658
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Patients with a previous cancer history (PCA) are routinely excluded from most clinical trials, which may limit the accuracy and universality of clinical trials. We aimed to explore the association between PCA and survival of patients with different molecular subtypes of breast cancer. Patients diagnosed with breast cancer from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015 were included in this retrospective cohort study. The primary outcome was overall survival (OS), which was calculated from date of diagnosis to date of death or censor date during this period. The relationship between PCA and OS of patients with different molecular subtypes of breast cancer was analyzed by the Kaplan-Meier curves and multivariate Cox proportional-hazards model. A total of 35,640 primary breast cancer patients were included, and 2,038 (5.72%) patients had a PCA. Female genital system cancer (491 cases, 24.09%) was the largest proportion type of previous cancer, and HER2-positive (24,754 cases, 69.46%) breast cancer was the most common subtype. Patients with previous female genital/endocrine system cancer history and other cancers history were associated with a poorer OS in overall patients, and in patients with triple-negative and HER2-positive subtypes (P < 0.05). In patients with Luminal A and Luminal B subtypes, previous other cancers history was related to poor OS (P < 0.05), while female genital/endocrine system cancer history may not influence the OS (P > 0.05). Subgroup analyses presented that PCA was related to poor OS in patients aged 40-64 years and & GE;65 years (P < 0.05), while prognosis in patients aged 18-40 years may not be influenced by PCA (P > 0.05). The impact of PCA on the prognosis of breast cancer patients was related to molecular type, patient age, and type of PCA. In clinical trials of breast cancer, the exclusion criteria for PCA patients may be modified according to the above variables.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] RETRACTED: The Effect of Endoscopy on Patients with Malignant Esophageal Cancer after Medical Treatment and Chemotherapy (Retracted Article)
    Liu, Yu
    Zhao, Lingqiong
    Tan, Xingping
    Liu, Nana
    Long, Teng
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [42] RETRACTED: Staged Nursing Intervention: The Effect of the Compliance in Liver Cancer Patients with Interventional Therapy (Retracted Article)
    Zhang, Limin
    Li, Xinsheng
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [43] RETRACTED: BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients (Retracted Article)
    Wang, L.
    Chunyan, Q.
    Zhou, Y.
    He, O.
    Ma, Y.
    Ga, Y.
    Wang, X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (18) : 4064 - 4070
  • [44] RETRACTED: Diagnosis of Breast Cancer Using Computational Intelligence Models and IoT Applications (Retracted Article)
    Alghamdi, Mohammed
    Maray, Mohammed
    Alazzam, Malik Bader
    COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE, 2022, 2022
  • [45] RETRACTED: Management of postoperative nausea and vomiting in women scheduled for breast cancer surgery (Retracted Article)
    Fujii, Yoshitaka
    JOURNAL OF ANESTHESIA, 2011, 25 (06) : 917 - 922
  • [46] RETRACTED: Analysis of the Influencing Factors of Sentinel Lymph Node Metastasis in Breast Cancer (Retracted Article)
    Lyu, Wei
    Guo, Yujuan
    Peng, Haiyan
    Xie, Nanyu
    Gao, Hongyi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [47] RETRACTED: Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer (Retracted Article)
    Acharya, Chaitanya R.
    Hsu, David S.
    Anders, Carey K.
    Anguiano, Ariel
    Salter, Kelly H.
    Walters, Kelli S.
    Redman, Richard C.
    Tuchman, Sascha A.
    Moylan, Cynthia A.
    Mukherjee, Sayan
    Barry, William T.
    Dressman, Holly K.
    Ginsburg, Geoffrey S.
    Marcom, Kelly P.
    Garman, Katherine S.
    Lyman, Gary H.
    Nevins, Joseph R.
    Potti, Anil
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (13): : 1574 - 1587
  • [48] RETRACTED: Lymphocyte Infiltration in Breast Cancer: A Key Prognostic Factor That Should Not Be Ignored (Retracted Article)
    Mouawad, Roger
    Spano, Jean-Philippe
    Khayat, David
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 1935 - 1936
  • [49] RETRACTED: Breast Cancer Classification Prediction Based on Ultrasonic Image Feature Recognition (Retracted Article)
    Huang, Yihong
    Zheng, Shuo
    Lin, Yu
    Miao, Haiyan
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [50] RETRACTED: Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis (Retracted Article)
    Yuan, Yingying
    Xu, Ming
    Ren, Yi
    He, Lili
    Chen, Jiejie
    Sun, Li
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022